Edition:
United Kingdom

Immunomedics Inc (IMMU.OQ)

IMMU.OQ on NASDAQ Stock Exchange Global Market

16.50USD
20 Apr 2018
Change (% chg)

$-0.20 (-1.20%)
Prev Close
$16.70
Open
$16.64
Day's High
$16.79
Day's Low
$16.35
Volume
623,068
Avg. Vol
725,324
52-wk High
$18.93
52-wk Low
$5.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec 0.60 -0.016
Sep 0.69 -0.811
FY 2017 Jun '17 0.64 -0.485
Mar '17 1.32 -0.550
Dec 0.38 -0.234
Sep 0.74 -0.169
FY 2016 Jun '16 0.93 -0.167
Mar '16 0.90 -0.148
Dec 0.67 -0.145
Sep 0.73 -0.163
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 1 3.30 3.30 3.30 --
Quarter Ending Mar-18 3 4.27 12.70 0.00 12.70
Year Ending Jun-18 3 9.93 27.00 1.30 65.90
Year Ending Jun-19 3 41.10 64.80 13.00 41.80
Earnings (per share)
Quarter Ending Dec-18 1 0.13 0.13 0.13 --
Quarter Ending Mar-18 3 -0.15 -0.04 -0.21 -0.07
Year Ending Jun-18 2 -0.96 -0.85 -1.07 0.01
Year Ending Jun-19 3 -0.40 0.50 -0.96 -0.10
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 84.02 32.74
P/E High - Last 5 Yrs. -- 293.18 45.72
P/E Low - Last 5 Yrs. -- 91.59 24.22
Beta 1.59 0.90 0.88
Price to Sales (TTM) 472.92 110.89 5.71
Price to Book (MRQ) -- 13.58 5.37
Price to Tangible Book (MRQ) -- 14.04 6.95
Price to Cash Flow (TTM) -- 71.40 23.32
% Owned Institutions 74.12 12.75 2.17

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg 0.00 0.26 1.51
Dividend 5 Year Growth Rate -- 1.66 5.32
Payout Ratio(TTM) -- 15.72 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -31.15 399.08 9.21
Sales (TTM) vs TTM 1 Yr. Ago -4.39 78.82 5.69
Sales - 5 Yr. Growth Rate -37.62 32.16 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago -189.81 25.00 19.36
EPS (TTM) vs TTM 1 Yr. Ago -130.72 -- --
EPS - 5 Yr. Growth Rate -- 38.99 10.76
Capital Spending - 5 Yr. Growth Rate 26.46 40.29 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.28 1.80 2.19
Current Ratio (MRQ) 1.29 5.30 2.98
LT Debt to Equity (MRQ) -- 22.96 12.18
Total Debt to Equity (MRQ) -- 24.62 16.45
Interest Coverage (TTM) -11.39 -99.35 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 84.39 40.02 54.44
Gross Margin - 5 Yr. Avg. 85.27 51.13 52.20
EBITD Margin (TTM) -2,530.57 -- --
EBITD - 5 Yr. Avg -950.32 -574.75 10.96
Operating Margin (TTM) -2,560.44 -718.53 4.73
Operating Margin - 5 Yr. Avg. -900.69 -596.06 6.40
Pre-Tax Margin (TTM) -4,957.38 -693.00 5.57
Pre-Tax Margin - 5 Yr. Avg. -1,202.66 -599.42 6.81
Net Profit Margin (TTM) -4,958.05 -694.22 1.87
Net Profit Margin - 5 Yr. Avg. -1,183.71 -602.27 3.09
Effective Tax Rate (TTM) -- 22.62 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.21 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 22,400 22,626,821 846,830,978
Net Income/Employee (TTM) -1,110,625 2,971,371 99,616,195
Receivable Turnover (TTM) 6.17 20.16 5.78
Inventory Turnover (TTM) 1.04 2.37 3.35
Asset Turnover (TTM) 0.03 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -139.64 -1.11 10.95
Return on Assets - 5 Yr. Avg. -85.73 -0.57 12.31
Return on Investment (TTM) -367.82 1.58 14.38
Return on Investment - 5 Yr. Avg. -119.48 2.21 16.10
Return on Equity (TTM) -- 2.41 16.07
Return on Equity - 5 Yr. Avg. -4,597.47 3.09 17.39
  1 Year 3 Year 5 Year
Sales % -4.39 -30.08 -37.62
EPS (TTM) % -135.27 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Immunomedics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -1.19 -4.59 72 53
13 Week 38.48 31.74 99 65
26 Week 99.15 84.01 99 77
52 Week 346.74 278.65 99 50
YTD 217.71 179.01 99 58
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 78.17%
# of Holders: 222
Total Shares Held: 129,585,685
3 Mo. Net Change: 1,617,102
# New Positions: 7
# Closed Positions: 3
# Increased Positions: 17
# Reduced Positions: 14
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.